Faculty Information - Kobari Yuuki

（Last updated : 2024-11-19 11:07:53）

Kobari Yuuki
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Urology

Position Assistant Professor

■ Published papers

1.	Original article	Comparative analysis of dual immune checkpoint inhibitor combination therapy versus immune checkpoint inhibitor plus tyrosine kinase inhibitor combination therapy for renal cell carcinoma with inferior vena cava tumor thrombosis. 2024/10
2.	Case report	Effectiveness of robot-assisted adrenalectomy for a giant adrenal hemangioma: A case report. 2024/09
3.	Original article	Robot-assisted partial nephrectomy with selective artery clamping for renal cell carcinoma in horseshoe kidney. 2024/07
4.	Original article	Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up. 2024/05/07
5.	Original article	First‑line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the efectiveness using real‑world data. 2024/04
6.	Case report	Safety of docetaxel in a patient with metastatic castration-resistant prostate cancer after kidney transplantation: A case report. 2024/04
7.	Original article	Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy. 2024/04
8.	Case report	Advanced renal cell carcinoma with Inferior vena cava thrombus treated with a combination of preoperative lenvatinib and pembrolizumab. 2024/03
9.	Original article	Comparisons of survival and surgical outcomes between minimally invasive partial nephrectomy and radical nephrectomy in elderly patients with stage 1 renal cell carcinoma. 2024/03
10.	Original article	Clinical course of candidate renal transplant recipients diagnosed with prostate cancer during pre-transplant screening test. 2024/01
11.	Original article	Higher risk of intraoperative bleeding in right-sided renal tumors compared to left-sided tumors in robot-assisted partial nephrectomy. 2023/07
12.	Case report	Long-time survival of a renal transplant recipient with metastatic mucinous tubular and spindle cell carcinoma: A case report. 2023/05
13.	Original article	Efficacy of combined pembrolizumab and pelvic radiotherapy for bladder cancer with rectal metastases. 2023/03
14.	Original article	Analyses of operative time according to procedure phases during robot-assisted laparoscopic partial nephrectomy using the iPhone application “My Intuitives” 2022/11
15.	Original article	Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma 2021/12
16.	Original article	Three cases of nivolumab plus ipilimumab therapy in haemodialysis patients with metastatic renal cell carcinoma. 2021/11
17.	Original article	Predictive impact of prognostic nutritional index on pembrolizumab for metastatic urothelial carcinoma resistant to platinum-based chemotherapy. 2021/03
18.	Original article	Comparison of postoperative recovery after robot-assisted partialnephrectomy of T1 renal tumors through retroperitoneal ortransperitoneal approach: A Japanese single institutional analysis. 2021/02
19.	Original article	Rapid Progressive Disease After Nivolumab Therapy in Three Patients with Metastatic Renal Cell Carcinoma. 2017/07
Display 5 items
Display all(19)

■ Academic conference presentation

1.	Impact of corticosteroid administration on treatment effectiveness in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitor-based combination therapy. 2024/05/03
2.	Clinical course of candidate renal transplant recipients diagnosed with prostate cancer during pre-transplant screening test. 2024/04/27
3.	Impact of gender on the efficacy of immune checkpoint inhibitor therapy in renal cell carcinoma. 2024/04/27
4.	BRCA mutation-positive prostate cancer at our hospital initial experience with olaparib in BRCA mutation-positive prostate cancer. 2024/04/26
5.	Efficiency of IO-IO combination therapy and IO-TKI combination therapy for renal cell carcinoma with inferior vena cava tumor thrombus. 2024/04/26
6.	Primary renal tumor response in patients treated with first-line systemic therapy for advanced renal cell carcinoma. 2024/04/26
7.	Utility of whole-body MRI (DWIBS) in treatment decision-making for M0CRPC: A case series study. 2024/04/26
8.	Comparison of Perioperative Outcomes between Robot-Assisted Laparoscopic Radical Nephroureterectomy and Laparoscopic Radical Nephroureterectomy. 2024/04/25
9.	Comparison of surgical outcomes between robot-assisted and conventional laparoscopic adrenalectomy at Tokyo Women's Medical University Hospital. 2024/04/25
10.	Comparisons of surgical outcomes of robot-assisted laparoscopic partial nephrectomy according to reconstruction methods, including single-layer and double-layer renorraphy: Analyses of an experienced surgeon. 2024/04/08
11.	Follow-up survey of candidate renal transplant recipients with prostate cancer diagnosed during the pre-transplant screening test. 2023/08/25
12.	Validation of predictive model for new baseline renal function after radical nephrectomy or robot-assisted partial nephrectomy in Japanese patients. 2023/04/29
13.	Initial experiences of robot-assisted adrenalectomy. 2023/04/22
14.	Medication states of up-front ARAT treatment for mHSPC in real-world practice. 2023/04/21
15.	Circulation kinetics analysis using computed tomography of papillary renal cell carcinoma, chromophobe renal cell carcinoma, oncocytoma, and angiomyolipoma. 2023/04/20
16.	Retzius-sparing robot-assisted radical prostatectomy in a renal transplant recipient. 2021/07/25
17.	The evaluation of living-related kidney transplantation donors in autosomal-dominant polycystic kidney disease. 2021/06/04
18.	Retroperitoneal approach is better quality of recovery than transperitoneal approach after robot-assisted partial nephrectomy. 2020/12/22
19.	Clinical future of mucinous tubular and spindle cell carcinoma of the kidney. 2019/08/17
Display 5 items
Display all(19)